文章预览
Why Attend this Event? · The recent interest cut by the US Federal Reserve opened the flood gate of biotech IPOs, and the sentiment of the biotech equity capital market feels the most optimistic since in the past years. · Join our distinguished panelists to explore key topics such as listing venue and vehicle selection, IPO vs. M vs. licensing dynamics, and the prospects for Asia-based biotech companies. · We will discuss the impact of geopolitical tensions and de-globalization on the IPO market, legal considerations for biotech companies and investors, and provide valuable advice on preparing for an IPO. · Gain insights into the latest trends and strategies in the biotech industry from the lens of the equity capital market. · Join our LinkedIn networking page here: https://www.linkedin.com/events/bioverseep14-howasia-basedbiote7246013122547789824/attendees/ Event details 主题： BioVerse episode 14 - The Global Trends in Biotech IPOs 时间: 2024年10月9日 Wed 9
………………………………
